| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0078 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 |
| filingDate |
1999-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2002-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002509154-A |
| titleOfInvention |
Novel pentasaccharide, process for producing the same, and pharmaceutical composition containing the same |
| abstract |
(57) Summary The present invention relates to pentasaccharides in acidic form and pharmaceutically acceptable salt forms thereof. Its anionic form has the formula: Wherein, - R 1 denotes a (C 1 -C 3) alkyl; - R is hydrogen or -SO 3 -, means (C 1 -C 3) alkyl or (C 2 -C 3) acyl group -T means hydrogen or an ethyl group; -n means 1 or 2]. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014517026-A |
| priorityDate |
1998-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |